These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12668184)
1. Inactivation of TSE agents: safety of blood and blood-derived products. Taylor DM Transfus Clin Biol; 2003 Feb; 10(1):23-5. PubMed ID: 12668184 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of the BSE agent. Taylor D C R Biol; 2002 Jan; 325(1):75-6. PubMed ID: 11862625 [TBL] [Abstract][Full Text] [Related]
3. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177 [TBL] [Abstract][Full Text] [Related]
4. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?]. Paul J Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380 [TBL] [Abstract][Full Text] [Related]
5. Tissue safety in view of CJD and variant CJD. Pauli G Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959 [TBL] [Abstract][Full Text] [Related]
6. Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years. Martin M; Trouvin JH Transfus Clin Biol; 2013 Sep; 20(4):398-404. PubMed ID: 23910008 [TBL] [Abstract][Full Text] [Related]
7. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Taylor DM; Fraser H; McConnell I; Brown DA; Brown KL; Lamza KA; Smith GR Arch Virol; 1994; 139(3-4):313-26. PubMed ID: 7832638 [TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease and the risk from blood or blood products. Will RG; Kimberlin RH Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease. Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892 [TBL] [Abstract][Full Text] [Related]
13. Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie. Unal A; Thyer J; Uren E; Middleton D; Braun M; Maher D Biologicals; 2007 Jun; 35(3):161-4. PubMed ID: 17074508 [TBL] [Abstract][Full Text] [Related]
14. Pathogen safety of manufacturing processes for biological products: special emphasis on KOGENATE Bayer. Lee DC; Miller JL; Petteway SR Haemophilia; 2002 Mar; 8 Suppl 2():6-9. PubMed ID: 11966845 [TBL] [Abstract][Full Text] [Related]
16. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Brown P; Brandel JP; Sato T; Nakamura Y; MacKenzie J; Will RG; Ladogana A; Pocchiari M; Leschek EW; Schonberger LB Emerg Infect Dis; 2012 Jun; 18(6):901-7. PubMed ID: 22607808 [TBL] [Abstract][Full Text] [Related]
17. Use of containment pans and lids for autoclaving caustic solutions. Brown SA; Merritt K Am J Infect Control; 2003 Jun; 31(4):257-60. PubMed ID: 12806365 [TBL] [Abstract][Full Text] [Related]
18. The safety of human blood: experimental TSE/prion infectivity studies. Cervenakova L Transfus Clin Biol; 2001 Jun; 8(3):260. PubMed ID: 11499973 [No Abstract] [Full Text] [Related]
20. Comparative study of the effects of several chemical and physical treatments on the activity of protease resistance and infectivity of scrapie strain 263K. Yao HL; Han J; Gao JM; Zhang J; Zhang BY; Guo YJ; Nie K; Gao C; Wang XF; Dong XP J Vet Med B Infect Dis Vet Public Health; 2005 Dec; 52(10):437-43. PubMed ID: 16364019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]